Related Experiment Video
Updated: Jul 3, 2026
08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
[Safety of adalimumab]
1Servicio de Dermatología. Hospital del Mar. Barcelona. España. mferran@imas.imim.es
Actas Dermo-Sifiliograficas
|August 19, 2008
Summary
Adalimumab
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Context:
- Adalimumab is an anti-tumor necrosis factor alpha (anti-TNFalpha) biologic therapy.
- Psoriasis is a chronic autoimmune skin condition.
- Understanding the safety profile of adalimumab in psoriasis is crucial for patient management.
Purpose:
- To evaluate the safety and adverse effects of adalimumab in patients with psoriasis.
- To compare the safety data of adalimumab in psoriasis to other approved indications.
- To inform clinical practice regarding patient screening and monitoring during adalimumab therapy.
Summary:
- Adalimumab demonstrates a safety profile in psoriasis consistent with other indications.
- Most adverse effects, such as injection site reactions and upper respiratory infections, are mild.
- Serious adverse effects, including infections and lymphoproliferative disorders, occur rarely, necessitating careful patient selection and monitoring.
Impact:
- Provides essential safety information for clinicians prescribing adalimumab for psoriasis.
- Highlights the need for long-term safety data and emphasizes vigilant patient monitoring.
- Contributes to informed decision-making in the management of psoriasis with biologic therapies.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...